Written by Private MD Labs Medical Writing Team • Last Updated: September 8, 2025
Cirrhosis is a late-stage scarring of the liver caused by various forms of liver disease and conditions, such as hepatitis and chronic alcoholism. While the diagnosis of cirrhosis typically involves imaging studies and sometimes liver biopsy, blood tests play a crucial role in assessing liver function, monitoring disease progression, identifying underlying causes, and detecting complications.
Cirrhosis can cause elevated ALT levels, indicating ongoing liver cell damage. This enzyme test is essential for monitoring the severity of liver inflammation and damage progression.
Blood tests are fundamental for managing cirrhosis as they help evaluate the extent of liver damage, monitor liver function, identify the underlying cause of liver disease, and detect complications such as liver cancer or heart dysfunction. These tests guide treatment decisions and help track the effectiveness of interventions.
AFP levels can increase in response to liver damage and cirrhosis, though levels are usually not as high as in liver cancer. This test helps monitor liver damage progression and screen for potential liver cancer development.
Cirrhosis impairs the liver's ability to process bilirubin effectively, leading to elevated levels of direct bilirubin. This test helps assess the severity of liver dysfunction and bile processing problems.
The liver damage from cirrhosis impairs its ability to function properly, leading to increased total bilirubin levels. This test provides a comprehensive view of the liver's bilirubin processing capability.
Cirrhosis can result in increased levels of ceruloplasmin, as this protein is produced in the liver and may increase as a response to chronic liver damage. This test helps assess liver synthetic function.
Chronic liver disease like cirrhosis can lead to elevated GGT levels. In cirrhosis, liver cells are gradually replaced by scar tissue, which can cause GGT to leak into the bloodstream, making this a valuable marker of liver damage.
Liver damage and cirrhosis can cause an increase in CA 19-9 levels. While primarily a tumor marker, elevated levels in cirrhosis patients may indicate liver dysfunction severity.
Chronic Hepatitis C can lead to cirrhosis over time. This comprehensive test identifies both past exposure and current active infection, which is crucial for determining if Hepatitis C is the underlying cause of cirrhosis.
Since chronic hepatitis infections can lead to cirrhosis, this comprehensive panel helps identify various forms of hepatitis that may be the underlying cause of liver damage and scarring.
Cirrhosis can lead to elevated CA-125 levels due to the liver's impaired function and associated complications. While primarily an ovarian cancer marker, it can be elevated in liver disease.
The presence of HCV RNA indicates ongoing Hepatitis C infection that may be causing or worsening cirrhosis. This test is essential for monitoring viral load and treatment effectiveness.
Cirrhosis can cause fluid buildup and increased pressure in liver blood vessels, leading to heart dysfunction and elevated BNP levels. The liver's inability to regulate fluids effectively can pressure the heart, making this test important for detecting cardiovascular complications.
Test results should always be interpreted by a healthcare provider who can consider your complete medical history, physical examination findings, and other diagnostic tests. Abnormal results may indicate the need for additional testing or specific treatments to manage cirrhosis and its complications.
The information here is for educational purposes only and is not a substitute for professional medical advice. Always consult with a healthcare provider for diagnosis, treatment, and management of cirrhosis.